Category Archives: Uncategorized

A new mobile app from the American Gastroenterological Association (AGA) provides instant recommendations for the management of patients with inflammatory bowel disease (IBD). It is now available from Apple’s app store. The app, which is called AGA’s Instant Recommendations for … Continue reading →

Researchers have identified small molecules that increase the ability of chemotherapeutic agents to kill pancreatic cancer cells and slow tumor growth in mice, according to the February issue of Gastroenterology. One way that chemotherapeutics such gemcitabine, 5-fluorouracil, and platinum-based compounds … Continue reading →

Nearly a quarter of screening colonoscopies performed in the Medicare population involve an anesthesiologist—a percentage that has more than doubled in the past 5 years, according to findings reported in the January issue of Clinical Gastroenterology and Hepatology. Many patients … Continue reading →

Which Roads Lead to NASH? The progressive liver disease nonalcoholic steatohepatitis (NASH) is mediated by an innate immune response in the liver that causes tissue damage and fibrosis. The innate immune system protects against invading pathogens, but it’s not clear … Continue reading →